DK1284754T3 - Gel-lignende farmaceutisk præparat som omfatter biphosphonsyrer eller salte deraf til subkutan administration - Google Patents
Gel-lignende farmaceutisk præparat som omfatter biphosphonsyrer eller salte deraf til subkutan administrationInfo
- Publication number
- DK1284754T3 DK1284754T3 DK01929595T DK01929595T DK1284754T3 DK 1284754 T3 DK1284754 T3 DK 1284754T3 DK 01929595 T DK01929595 T DK 01929595T DK 01929595 T DK01929595 T DK 01929595T DK 1284754 T3 DK1284754 T3 DK 1284754T3
- Authority
- DK
- Denmark
- Prior art keywords
- salts
- gel
- pharmaceutical composition
- subcutaneous administration
- biphosphonic acids
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 150000007513 acids Chemical class 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 238000007920 subcutaneous administration Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229940122361 Bisphosphonate Drugs 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 150000004663 bisphosphonates Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10021917 | 2000-05-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1284754T3 true DK1284754T3 (da) | 2006-05-01 |
Family
ID=7640900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01929595T DK1284754T3 (da) | 2000-05-05 | 2001-04-23 | Gel-lignende farmaceutisk præparat som omfatter biphosphonsyrer eller salte deraf til subkutan administration |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6676970B2 (da) |
| EP (1) | EP1284754B1 (da) |
| JP (1) | JP3923800B2 (da) |
| KR (1) | KR100492110B1 (da) |
| CN (1) | CN1180846C (da) |
| AR (2) | AR033671A1 (da) |
| AT (1) | ATE314862T1 (da) |
| AU (1) | AU778431B2 (da) |
| BR (1) | BR0110618A (da) |
| CA (1) | CA2407747C (da) |
| DE (1) | DE60116483T2 (da) |
| DK (1) | DK1284754T3 (da) |
| ES (1) | ES2254410T3 (da) |
| MX (1) | MXPA02010740A (da) |
| WO (1) | WO2001085217A1 (da) |
| ZA (1) | ZA200208499B (da) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1365770A2 (en) * | 2001-02-07 | 2003-12-03 | Durect Corporation | Devices and methods for management of bone density |
| US7875597B2 (en) * | 2002-07-24 | 2011-01-25 | New York University | Treatment of spinal mechanical pain |
| CN100364544C (zh) * | 2004-07-21 | 2008-01-30 | 上海第二医科大学附属瑞金医院 | 一种携带二氯亚甲基二膦酸的明胶微粒及制备方法 |
| DE602005025977D1 (de) * | 2004-08-23 | 2011-03-03 | Teva Pharma | Kristalline form des ibandronat-natriums und herstellungsverfahren dafür |
| US7294195B2 (en) * | 2005-08-08 | 2007-11-13 | Wacker Chemical Corporation | Water repellant gypsum compositions |
| ITMI20052515A1 (it) * | 2005-12-29 | 2007-06-30 | Abiogen Pharma Spa | Formulazione farmaceutica per il trattamento della osteoartrite |
| EP1923049A1 (en) * | 2006-11-17 | 2008-05-21 | Besins Healthcare | Pharmaceutical compositions comprising a bisphosphonate compound |
| CA2669488A1 (en) * | 2006-11-17 | 2008-05-22 | Besins Healthcare | Pharmaceutical compositions comprising a bisphosphonate compound |
| US8974801B2 (en) * | 2006-12-21 | 2015-03-10 | Amphastar Pharmaceuticals Inc. | Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate |
| EP1992364A1 (en) * | 2007-05-16 | 2008-11-19 | Biosuma S.r.l. | Carboxylated polysaccharides phosphated or bisphosphonated derivatives, optionally cross-linked, and their preparation and biomedical uses |
| WO2009128918A1 (en) * | 2008-04-14 | 2009-10-22 | Halozyme, Inc. | Combination therapy using a soluble hyaluronidase and a bisphosphonate |
| WO2010111627A1 (en) * | 2009-03-26 | 2010-09-30 | Psivida Us, Inc. | Implantable formulations of bisphosphonic acids |
| DK2459176T3 (da) * | 2009-07-31 | 2017-12-04 | Gruenenthal Gmbh | Krystallisationsfremgangsmåde og biotilgængelighed |
| US20160016982A1 (en) | 2009-07-31 | 2016-01-21 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
| US9169279B2 (en) | 2009-07-31 | 2015-10-27 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
| CN102000094B (zh) * | 2010-09-27 | 2013-03-27 | 天津南开允公医药科技有限公司 | 一种含有伊班膦酸的药物组合物及制备工艺 |
| WO2012048285A1 (en) * | 2010-10-08 | 2012-04-12 | Lanco Biosciences, Inc. | Delivery of bisphosphonates by microinjection systems |
| US9340565B2 (en) | 2010-11-24 | 2016-05-17 | Thar Pharmaceuticals, Inc. | Crystalline forms |
| GB201412236D0 (en) * | 2014-07-09 | 2014-08-20 | Univ Nottingham | Method of producing and using alginate hydrogels |
| JP6980360B2 (ja) * | 2014-09-03 | 2021-12-15 | 日東電工株式会社 | ビスホスホネート剤を含む液性免疫用ワクチン医薬組成物 |
| US10195218B2 (en) | 2016-05-31 | 2019-02-05 | Grunenthal Gmbh | Crystallization method and bioavailability |
| IT201800009444A1 (it) | 2018-10-15 | 2020-04-15 | Fidia Farm Spa | Coniugati tra acido ialuronico e amminobisfosfonati e loro impiego terapeutico |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE61111C (de) | B. WINKLER in Berka a. Werrä | Verfahren zur Herstellung von Knöpfen ohne Fadenbefestigung | ||
| US4446052A (en) * | 1982-05-17 | 1984-05-01 | The Procter & Gamble Company | Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate |
| DE3512536A1 (de) * | 1985-04-06 | 1986-10-16 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue diphosphonsaeure-derivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| DE3540150A1 (de) | 1985-11-13 | 1987-05-14 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| DE3623397A1 (de) | 1986-07-11 | 1988-01-14 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| DE3626058A1 (de) | 1986-08-01 | 1988-02-11 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| DE3640938A1 (de) | 1986-11-29 | 1988-06-01 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindung enthaltende arzneimittel |
| DE3822650A1 (de) | 1988-07-05 | 1990-02-01 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| US4922077A (en) | 1989-01-31 | 1990-05-01 | Raytheon Company | Method of laser marking metal packages |
| CA2035179C (en) * | 1990-01-31 | 2001-08-14 | Gerald S. Brenner | Pharmaceutical compositions containing insoluble salts of bisphosphonic acids |
| DE4223940A1 (de) * | 1992-07-21 | 1994-01-27 | Boehringer Mannheim Gmbh | Neue acyclische Amidingruppen-haltige Diphosphonsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE4228552A1 (de) * | 1992-08-27 | 1994-03-03 | Boehringer Mannheim Gmbh | Diphosphonsäuren und deren Salze enthaltende Arzneimittel |
| DE4244422A1 (de) | 1992-12-29 | 1994-06-30 | Boehringer Mannheim Gmbh | Schwerlösliche Zink- und Magnesiumsalze von 1,1-Bisphosphonsäuren, ihre Herstellung und Verwendung als Arzneimittel |
| DE4244423A1 (de) | 1992-12-29 | 1994-06-30 | Boehringer Mannheim Gmbh | Wasserlösliche Calciumsalze der 1-Hydroxy-3-(methylpentylamino)propan-1,1-bisphosphonsäure, ihre Herstellung und Verwendung als Arzneimittel |
| US5780455A (en) * | 1994-08-24 | 1998-07-14 | Merck & Co., Inc. | Intravenous alendronate formulations |
| US5652227A (en) * | 1995-01-30 | 1997-07-29 | Teronen; Olli Pekka | Inhibition of the degradation of connective tissue matrix protein components in mammals |
| US5994329A (en) * | 1997-07-22 | 1999-11-30 | Merck & Co., Inc. | Method for inhibiting bone resorption |
| SE9901272D0 (sv) * | 1999-04-09 | 1999-04-09 | Astra Ab | New improved formulation |
-
2001
- 2001-04-23 JP JP2001581870A patent/JP3923800B2/ja not_active Expired - Lifetime
- 2001-04-23 CN CNB018089771A patent/CN1180846C/zh not_active Expired - Fee Related
- 2001-04-23 CA CA002407747A patent/CA2407747C/en not_active Expired - Fee Related
- 2001-04-23 EP EP01929595A patent/EP1284754B1/en not_active Expired - Lifetime
- 2001-04-23 KR KR10-2002-7014837A patent/KR100492110B1/ko not_active Expired - Fee Related
- 2001-04-23 BR BR0110618-0A patent/BR0110618A/pt not_active IP Right Cessation
- 2001-04-23 DK DK01929595T patent/DK1284754T3/da active
- 2001-04-23 WO PCT/EP2001/004550 patent/WO2001085217A1/en not_active Ceased
- 2001-04-23 AU AU56317/01A patent/AU778431B2/en not_active Ceased
- 2001-04-23 AT AT01929595T patent/ATE314862T1/de active
- 2001-04-23 ES ES01929595T patent/ES2254410T3/es not_active Expired - Lifetime
- 2001-04-23 MX MXPA02010740A patent/MXPA02010740A/es active IP Right Grant
- 2001-04-23 DE DE60116483T patent/DE60116483T2/de not_active Expired - Lifetime
- 2001-05-03 US US09/848,638 patent/US6676970B2/en not_active Expired - Lifetime
- 2001-05-03 AR ARP010102090A patent/AR033671A1/es not_active Application Discontinuation
-
2002
- 2002-10-21 ZA ZA200208499A patent/ZA200208499B/en unknown
-
2006
- 2006-08-31 AR ARP060103816A patent/AR055407A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003532689A (ja) | 2003-11-05 |
| AU778431B2 (en) | 2004-12-02 |
| BR0110618A (pt) | 2003-04-29 |
| WO2001085217A1 (en) | 2001-11-15 |
| ZA200208499B (en) | 2004-02-26 |
| EP1284754A1 (en) | 2003-02-26 |
| CA2407747C (en) | 2008-03-11 |
| EP1284754B1 (en) | 2006-01-04 |
| KR100492110B1 (ko) | 2005-06-02 |
| JP3923800B2 (ja) | 2007-06-06 |
| AU5631701A (en) | 2001-11-20 |
| CN1180846C (zh) | 2004-12-22 |
| AR033671A1 (es) | 2004-01-07 |
| CN1427727A (zh) | 2003-07-02 |
| DE60116483D1 (de) | 2006-03-30 |
| ES2254410T3 (es) | 2006-06-16 |
| CA2407747A1 (en) | 2001-11-15 |
| US6676970B2 (en) | 2004-01-13 |
| US20010053388A1 (en) | 2001-12-20 |
| ATE314862T1 (de) | 2006-02-15 |
| DE60116483T2 (de) | 2006-09-07 |
| AR055407A2 (es) | 2007-08-22 |
| MXPA02010740A (es) | 2003-03-10 |
| KR20030009470A (ko) | 2003-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2407747A1 (en) | Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts | |
| AR109170A2 (es) | Esfingomielinasa ácida para uso en la prevención o el tratamiento de la enfermedad de niemann-pick a o b en un paciente | |
| AR110986A2 (es) | Composiciones de ecteinascidina, formulaciones liofilizadas, método de preparación y uso | |
| CY1121877T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει πιμοβενδανη | |
| WO2009032034A3 (en) | Stabilized picoplatin dosage form | |
| AR033423A1 (es) | Sales farmaceuticas constituidas de una sustancia activa farmaceutica y al menos un edulcorante, medicamentos que contienen estas sales y uso de estas sales para la preparacion de medicamentos | |
| BRPI0411678A (pt) | nanopartìculas de ácido hialurÈnico | |
| SI1687019T1 (en) | Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices | |
| DE60133323D1 (de) | Cardioprotektive Phosphonate | |
| WO2011063952A8 (en) | Formulations of bisphosphonates and vitamin d suitable for intermittent intramuscular and subcutaneous administration | |
| EA200970726A1 (ru) | Твердый препарат, содержащий алоглиптин и пиоглитазон | |
| CY1112185T1 (el) | Σταθερο συμπλοκο δραστικων ουσιων απο αλατα των o-ακετυλοσαλικυλικων οξεων με βασικα αμινοξεα και γλυκινη | |
| BRPI0508579A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| EP1633327A4 (en) | METHOD FOR IMPROVING THE STABILITY AND DURABILITY OF LIPOSOME COMPLEXES | |
| BRPI0417932A (pt) | lipólise medicamentosa de acúmulo de gordura | |
| NO20076425L (no) | Fremgangsmater for behandling av drug-resistent cancer | |
| CY1109120T1 (el) | Φαρμακευτικη συνθεση βινφλουνινης που προοριζεται για παρεντερικη χορηγηση, μεθοδος παρασκευης και χρησης | |
| WO2009087682A3 (en) | Stabilized injectable formulation of pregabalin | |
| UA122762C2 (uk) | Пероральна композиція 9-[(2,2-диметилпропіламіно)-метил]-міноцикліну або його солі, тверда пресована дозована форма, композиція для ін'єкцій, застосування та спосіб приготування фармацевтичної композиції | |
| BR0110892A (pt) | Forma de administração farmacêutica para peptìdios, processos para preparação e uso dos mesmos | |
| ID29025A (id) | Fenilalkenoilguanidina-fenilalkenoilguanidina yang disubstitusi asam empedu, proses pembuatannya, penggunaannya sebagai obat atau diaknostik dan obat-obat yang mengandungnya | |
| MXPA05010613A (es) | Formulacion parenteral de acido micofenolico, una sal o profarmaco del mismo. | |
| DE602006018467D1 (de) | Schnell lösliche Formulierung von nichtsteroidalen Antiphlogistika | |
| EP1552838A4 (en) | RUBROFUSARIN GLYCOSIDE-CONTAINING COMPOSITION | |
| EA200501252A1 (ru) | Липосомальная композиция, способ ее получения и лекарственное средство на ее основе (варианты) |